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Abstract
Small non-coding RNAs (sRNAs) that act as regulators of gene expression have been identified in all kingdoms of life,
including microRNA (miRNA) and small interfering RNA (siRNA) in eukaryotic cells. Numerous sRNAs identified in Salmonella
are encoded by genes located at Salmonella pathogenicity islands (SPIs) that are commonly found in pathogenic strains.
Whether these sRNAs are important for Salmonella pathogenesis and virulence in animals has not been reported. In this
study, we provide the first direct evidence that a pathogenicity island-encoded sRNA, IsrM, is important for Salmonella
invasion of epithelial cells, intracellular replication inside macrophages, and virulence and colonization in mice. IsrM RNA is
expressed in vitro under conditions resembling those during infection in the gastrointestinal tract. Furthermore, IsrM is
found to be differentially expressed in vivo, with higher expression in the ileum than in the spleen. IsrM targets the mRNAs
coding for SopA, a SPI-1 effector, and HilE, a global regulator of the expression of SPI-1 proteins, which are major virulence
factors essential for bacterial invasion. Mutations in IsrM result in disregulation of expression of HilE and SopA, as well as
other SPI-1 genes whose expression is regulated by HilE. Salmonella with deletion of isrM is defective in bacteria invasion of
epithelial cells and intracellular replication/survival in macrophages. Moreover, Salmonella with mutations in isrM is
attenuated in killing animals and defective in growth in the ileum and spleen in mice. Our study has shown that IsrM sRNA
functions as a pathogenicity island-encoded sRNA directly involved in Salmonella pathogenesis in animals. Our results also
suggest that sRNAs may represent a distinct class of virulence factors that are important for bacterial infection in vivo.
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Introduction
Salmonella (e.g. S. enterica serovars Typhimurium and Enteritidis)
is the leading cause of food-borne illnesses in the United States,
causing diverse diseases ranging from mild, self-limiting gastroen-
teritis to life-threatening systemic infection [1]. As a facultative
intracellular pathogen, Salmonella invades non-phagocytic cells
such as intestinal epithelial cells and replicates in phagocytes
during systemic infection. Two hallmarks of Salmonella pathogen-
esis, i.e. host invasion and intracellular proliferation, correlate with
the genes in Salmonella pathogenicity islands (SPIs), which are
distinct, relatively large chromosomal regions harboring virulence
genes and are commonly found in pathogenic strains [2,3]. For
example, Salmonella pathogenicity island 1 (SPI-1) contains
invasion genes, while Salmonella pathogenicity island 2 (SPI-2)
contains genes required for intracellular survival and replication
[4,5,6]. Both SPI-1 and SPI-2 encode type III secretion systems
(T3SS), which are specialized organelles that deliver effector
proteins to the cytosol of host cells [3,7]. The T3SS apparatus is a
needle-like structure that spans the inner and outer membranes of
the bacterial envelope and penetrates host cell membranes.
Through T3SS Salmonella secretes translocon proteins that allow
the delivery of effector proteins into eukaryotic cells [3,7], leading
to modulation of host cells and immune responses, and promotion
of bacterial pathogenesis [4,5,6]. Highly regulated expression of
the genes in SPIs and those encoding their effector proteins is
observed both in vitro and in vivo and is required for bacterial
pathogenesis and infection [6,8].
The regulation of expression of genes coding for SPI-1 proteins
and its effectors is remarkably complex and is yet to be fully
characterized [8]. For example, the expression of some genes
coding for SPI-1 proteins, including SopA, has been shown to be
induced upon invasion of both macrophages and epithelial cells
and at the late stage of Salmonella infection in animals
[9,10,11,12,13]. These results suggest that in addition to their
generally recognized roles in invasion, the SPI-1 factors may play
an important role post-invasion, possibly in intracellular replica-
tion/survival.
Small non-coding RNAs (sRNAs) that act as regulators of gene
expression have been identified in all kingdoms of life, including
microRNA (miRNA) and small interfering RNA (siRNA) in
eukaryotic cells [14,15,16,17]. The bacterial sRNAs are generally
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play diverse physiological roles such as those in the regulation of
stress responses and metabolism, and control of bacterial envelope
composition [16,18,19]. The mechanisms by which bacterial
sRNAs modulate gene expression are diverse, and two general
modes of action have been established, dividing regulatory sRNAs
into two classes [16,18,19,20]. One class of sRNAs acts by
interacting with a protein target to modify its activity [21,22]. The
other class of sRNAs acts by base-pairing with one or more target
RNAs. Most of these antisense RNAs base-pair with target
mRNAs in trans with partial complementarity to modulate their
translation and/or stability [16,17,20].
While many protein factors (e.g. SPI-1 and SPI-2 factors) are
shown to be important for bacterial pathogenesis, little is known
about the functions of sRNAs in Salmonella virulence. Recently
novel sRNA genes have been identified within the SPIs [23,24,25].
The expression of many of these sRNA genes is associated with
stress conditions and the stationary phase [25]. In addition, several
SPI-encoded sRNAs were found to be expressed in Salmonella that
resides within macrophages [23]. The location of these sRNA
genes in the SPIs suggests that these sRNAs may play important
roles in bacterial pathogenesis and virulence.
Here we demonstrate that a SPI-encoded sRNA, IsrM sRNA,
modulates the differential expression of SPI-1 genes by indepen-
dently targeting the mRNAs of both the global SPI-1 regulator
HilE and specific SPI-1 effector SopA. Salmonella with mutations in
isrM is defective in bacterial invasion and intracellular replication
in vitro, and in virulence and colonization in infected mice. To our
knowledge, IsrM is the first pathogenicity island-encoded RNA
known to be important in Salmonella pathogenesis in vivo. Our study
suggests that sRNAs may represent a distinct class of virulence
factors that significantly contribute to bacterial pathogenesis in vivo.
Results
Expression of IsrM RNA in vitro under conditions
resembling those of the gastrointestinal tract
Because IsrM is a pathogenicity island-specific sRNA of
Salmonella and is not found in E.coli [23], it is conceivable that
IsrM plays a role in pathogenesis of Salmonella. The gene encoding
IsrM can be found in several serovars of Salmonella such as
Salmonella typhimurium but not other serovars such as Salmonella typhi
or Samonella bongori (Figure 1). It is currently unclear why IsrM is
found in some serovars but not other serovars of Salmonella,
although it is possible that the presence of IsrM in a specific
serovar may be related to the unique pathogenesis of the serovar in
a particular host. IsrM is expressed as a 329-nucleotide RNA at
both the logarithm (log) and stationary growth phases, and is
expressed at a moderate level in Salmonella isolated from J774
macrophages [23]. However, little is currently known about the
expression of IsrM in vitro under conditions resembling those at
early stages of infection, and its expression during Salmonella
infection in vivo has not been reported.
During natural infection via the oral route, Salmonella encounters
a series of environmental changes in the gastrointestinal track that
prime Salmonella for invasion of the intestinal epithelium
[26,27,28,29,30,31,32]. To study the role of IsrM in Salmonella
invasion, we exposed Salmonella to three different stimuli that
resembled those Salmonella likely encounters during the early stages
of its oral infection: pH, osmolarity, and oxygen limitation. The
expression of IsrM was examined using quantitative RT-PCR
(qRT-PCR) assays with the level of 16S rRNA as the internal
control (Figure 2A–C).
During enteric infection, Salmonella needs to survive in the
stomach, which is acidic, before establishing colonization in the
intestine, which is relatively basic. Quantitative RT-PCR assays
showed that IsrM had higher expression at pH3.0, pH4.4, and
pH7.2, with the highest expression at pH3.0, compared to that at
pH7.0 (Figure 2A). These results were further confirmed using
Northern blot analyses. For example, using the level of 5S RNA as
the internal control, Northern analyses showed that the level of
IsrM was higher at pH4.4 than at pH7.0 (Figure S1)(Supporting
Information). These observations suggest that this sRNA may be
expressed as early as in the stomach during Salmonella infection in
vivo. High osmolarity is an environmental stress that bacteria
encounters in the intestine, and is believed to promote Salmonella
adhesion and invasion of intestinal epithelial cells, contributing to
its virulence [28]. Increasing osmolarity up to 85 mM NaCl
favored the expression of IsrM (Figure 2B). Oxygen limitation, an
important characteristic of the environment in the intestine, can
induce Salmonella invasiveness of intestinal mucosa while aerobic
conditions render Salmonella less invasive [29,30,31,32]. In our
experiments, IsrM expression was moderately induced by oxygen
limitation (Figure 2C). Thus, IsrM RNA was apparently expressed
under conditions that resembled the early stages of its oral
infection in the gastrointestinal tract.
Expression of IsrM during Salmonella infection in vivo
Both immunocompetent BALB/c mice and immunodeficient
SCID mice were infected intraperitoneally to study IsrM
expression during systemic bacterial infection. Immunodeficient
animals, such as the CB17 SCID mice that lack functional T and
B lymphocytes, are extremely susceptible to Salmonella infection
[12,13]. Analysis of bacterial growth in these mice can be used for
comparing the virulence and studying the pathogenesis of different
bacterial strains and mutants [12,13]. At different time points
postinfection, the spleen and ileum were harvested. Quantitative
RT-PCR was carried out to determine the expression of IsrM
RNA in Salmonella isolated from the tissues, using the expression of
bacterial 16S rRNA as the internal control (Figure 2D). Normal-
ization of samples was also carried out by using total RNAs
extracted from the same colony forming unit (CFU) (e.g.
5610
4 CFU) of bacteria. Similar amounts of 16S rRNA were
detected from same CFU Salmonella regardless of infection route
Author Summary
Regulated expression of virulence factors is essential for
infection by human pathogens such as Salmonella. Small
non-coding RNAs (sRNAs) that act as regulators of gene
expression have been identified in all kingdoms of life, and
many sRNAs in Salmonella are encoded by genes located
at Salmonella pathogenicity islands commonly found in
pathogenic strains. In this study, we demonstrated that a
pathogenicity island-encoded sRNA directly targets the
expression of both a global regulator of virulence genes as
well as a specific virulence factor critical for Salmonella
pathogenesis. The sRNA is important for Salmonella
invasion of epithelial cells, replication inside macrophages,
and virulence/colonization in mice, representing the first
example of a pathogenicity island-encoded sRNA that is
directly involved in Salmonella pathogenesis in vivo. Our
study suggests that sRNA may function as a distinct class
of virulence factors that significantly contribute to
bacterial infection in vivo. Furthermore, our results raise
the possibility of developing new strategies against
bacterial infection by preventing the expression of
regulatory sRNAs.
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(12–24 hours or 5–7 days) (data not shown), suggesting that the
level of 16S rRNA was not significantly different in bacteria from
the spleen and ileum. Salmonella presumably trafficked to the ileum
tissue via the lymphatic system in intraperitoneally-infected mice,
while in intragastrically-infected mice, the bacteria could directly
invade and infect the ileum tissue.
Salmonella isolated from both the spleen and ileum of SCID mice
at 18 hours postinfection were found to express IsrM, with its
expression in the ileum approximately 2.5-fold higher than that in
the spleen (Figure 2D). To rule out the residual expression of IsrM
from in vitro bacterial growth, mice were intraperitoneally infected
with bacteria for a longer period and tissues were harvested at 7
days postinfection. We also found that IsrM was expressed in both
organs, with its expression in the ileum approximately 2.5-fold
higher than that in the spleen. Similar results were also observed in
bacteria isolated from the organs of the intraperitoneally-infected
BALB/c mice (data not shown).
SCID mice were also infected intragastrically with bacteria in
order to study whether IsrM is expressed during Salmonella
infection acquired by the oral route. Spleens and ileums were
collected and the bacteria were recovered at 18 hrs and 7 days
postinfection. IsrM was detected in Salmonella isolated from both
the spleen and ileum, with its level in the ileum approximately 2.5-
fold higher than that in the spleen (Figure 2D). Similar results were
also observed in Salmonella isolated from the organs of infected
BALB/c mice. Taken together, these results suggest that IsrM is
expressed during the early and late stages of Salmonella infection,
and that it is differentially expressed, with higher expression in the
ileum than in the spleen.
IsrM is dispensable for Salmonella growth in vitro but
important for the expression of Salmonella SPI-1 proteins
To investigate the role of IsrM in Salmonella growth, a mutant,
DIsrM, was derived from the wild type S. typhimurium 14028s strain
by deleting the IsrM sequence. Mutant DIsrM grew as well as
ST14028s in LB broth (Figure S2A)(Supporting Information),
indicating that IsrM is dispensable for bacterial growth in vitro.
The unique presence of IsrM in a SPI region and its induced
expression in the ileum suggests that IsrM may play a role in the
Figure 1. Alignment of isrM sequences of different Salmonella strains including the upstream promoter region, based on BLAST
searches of the IsrM sequences in GenBank. The transcription start sites, 210 boxes, 235 boxes, and transcription terminators of isrM genes are
boxed and in red [23]. The targeting sequences for SopA and HilE mRNAs that were identified in this study are boxed and in green.
doi:10.1371/journal.ppat.1002120.g001
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are major virulence determinants essential for Salmonella invasion
[3,7], we reasoned that IsrM may function to regulate the
expression of SPI-1 factors, facilitating Salmonella infection and
pathogenesis. To investigate this possibility, we examined the
effect of a deletion of the IsrM sequence on the expression of SPI-
1 factors. Bacterial strains T-invJ, T-sopE2, T-sptP, T-spaO, T-
sipD, T-sipC, T-sipB, T-sipA, T-sopB, and T-sopA were
previously derived from the wild type Salmonella strain
ST14028s by inserting the FLAG epitope tag sequence into
SPI-1 ORFs invJ, sopE2, sptP, spaO, sipD, sipC, sipB, sipA, sopB,a n d
sopA, respectively [12,13]. Tagging of the SPI-1 ORFs in these
mutants did not impair the invasiveness, growth, or the virulence
of the bacteria, and the tagged strains can be used as model
strains to study the infection of Salmonella in vitro and in vivo,
including the expression of SPI-1 proteins and effectors [12,13].
We constructed mutants DM-T-invJ, DM-T-sopE2, DM-T-sptP,
DM-T-spaO, DM-T-sipD, DM-T-sipC, DM-T-sipB, DM-T-sipA,
DM-T-sopB, and DM-T-sopA from T-invJ, T-sopE2, T-sptP, T-
spaO, T-sipD, T-sipC, T-sipB, T-sipA, T-sopB, and T-sopA,
respectively, by deleting the IsrM sequence in each SPI-1 tagged
strain (Table 1). These newly constructed isrM-deletion mutant
strains grew as well as the parental strains and the wild type
ST14028s in LB broth (Figure S2B)(Supporting Information),
consistent with our results (Figure S2A)(Supporting Information)
that IsrM is not essential for bacterial growth in vitro.
We performed Western analyses to determine the expression of
the tagged SPI-1 proteins with an anti-FLAG antibody, using the
expression of bacterial DnaK protein as the internal control
(Figure 3A). Normalization of samples was also carried out by
loading total protein extracted from the same CFU (e.g.
5610
7 CFU) of bacteria in each lane. The levels of the tagged
InvJ, SpoE2, SptP, SpaO, SipD, SipC, SipB, SipA, and SopB
proteins in the IsrM deletion strains were found to be lower than
Figure 2. Expression of IsrM RNA in Salmonella. Salmonella was grown either in vitro (A–C) or in mice (D). Effect of pH values (A), osmolarity (B),
and limitation of oxygen (C). Cultures of ST14028s were grown in culture media at different pH, at various concentrations of NaCl, or in the presence
and limitation of oxygen. The values of the relative expression, which are the means from triplicate experiments, represent the ratios of the levels of
IsrM under each pH condition to that under the control pH7.0 condition (A), the ratios of the levels of IsrM under different osmolarity conditions to
that under the control condition of 170 mM NaCl as in regular LB broth (B), or the ratios of the level of IsrM under oxygen limitation to that under the
control condition (i.e. in the presence of oxygen) (C). The analyses were repeated three times. The standard deviation is indicated by the error bars.
(D) Level of IsrM from Salmonella recovered from the spleen and ileum of infected mice. SCID mice were intraperitoneally (IP) or intragastrically (IG)
infected with ST14028s, and bacteria were recovered from the organs at 18 hours or 7 days post inoculation, respectively. The values in the IP and IG
experiments, which are the means from triplicate experiments, represent the relative level of IsrM in ST14028s recovered from the spleen and ileum,
as compared to the level of IsrM in Salmonella recovered from the spleen of the IP- and IG-infected mice at 18 hours post inoculation, respectively.
doi:10.1371/journal.ppat.1002120.g002
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level of SopA in the IsrM-deletion strain (i.e. DM-T-sopA) was
found to be approximately 2.5-fold higher than that in the
parental T-sopA strain (Figure 3A, compare lanes 1 and 2).
Transformation of plasmid pIsrM, which contained the sequence
of IsrM under its native promoter and transcriptional terminator
sequence, in the deletion mutants restored the levels of the tagged
proteins to the wildtype levels (Figure 3, lanes 3 and 6). Using 16S
rRNA as the internal control, qRT-PCR assays showed that the
levels of IsrM were similar in the parental strain T-sopA and the
deletion mutant DM-T-SpoA that contained the complementation
construct pIsrM (data not shown). Taken together, these results
suggest that deletion of IsrM may lead to a global disregulation of
expression of the SPI-1 proteins.
Targeting the 59 untranslated region (UTR) of the HilE
mRNA by IsrM
Bacterial sRNAs generally function to modulate gene expression
by hybridizing to the target mRNAs [18,19,20]. No targets for
IsrM have been reported. Using the TargetRNA and RNAhybrid
algorithms, we searched the regions of Salmonella mRNAs for
potential RNA duplex formation with IsrM [33,34]. This analysis
predicted stable pairing of two distinct and non-overlapping
regions of IsrM with the entire Shine-Dalgarno (SD) sequence of
hilE and sopA mRNAs, respectively (Figure 4A–B), which may
cause translational repression [18,19,20].
HilE is a negative global regulator of the expression of many
SPI-1 genes by sequestering HilD, a major SPI-1 transcriptional
activator [8,35]. To determine if IsrM regulates hilE,w e
constructed a tagged hilE strain T-hilE by inserting the FLAG
epitope tag sequence into hilE of ST14028s and furthermore, a
corresponding isrM deletion mutant of T-hilE, DM-T-hilE
(Table 1). Both T-hilE and DM-T-hilE grew as well as
ST14028s in LB broth, and tagging of hilE did not impair the
invasiveness, growth, or the virulence of the bacteria in mice (data
not shown).
Using the expression level of DnaK as the internal control,
Western blot analyses with an anti-FLAG antibody indicated that
deletion of IsrM increased the level of HilE (Figure 5, compare
lane 1 and 4). Transformation of plasmid pIsrM carrying the IsrM
sequence with the native promoter and transcriptional terminator
reduced the HilE expression to the wildtype level in DM-T-hilE
(Figure 5, lane 2), suggesting that IsrM specifically modulates the
protein level of HilE.
To investigate the potential interactions between IsrM and hilE
mRNA, we used a two plasmid system [36] that involved co-
Table 1. Bacterial strains used in this study.
Bacterial strains Description Reference/source
ST14028S Wild type and parental strain [50]
DIsrM-P ST14028S isrM::kan, polar strain This study
DIsrM ST14028S, isrM deleted, without kanR This study
T-invJ ST14028S invJ::1xFLAG [13]
DM-T-invJ ST14028S invJ::1xFLAG isrM::kanR This study
T-sipA ST14028S sipA::1xFLAG [12]
DM-T-sipA ST14028S sipA::1xFLAG isrM::kanR This study
T-sipB ST14028S sipB::1xFLAG [12]
DM-T-sipB ST14028S sipB::1xFLAG isrM::kanR This study
T-sipC ST14028S sipC::1xFLAG [13]
DM-T-sipC ST14028S sipC::1xFLAG isrM::kanR This study
T-sipD ST14028S sipD::1xFLAG [13]
DM-T-sipD ST14028S sipD::1xFLAG isrM::kanR This study
T-sopA ST14028S sopA::1xFLAG [13]
DM-T-sopA ST14028S sopA::1xFLAG isrM::kanR This study
T-sopB ST14028S sopB::1xFLAG [13]
DM-T-sopB ST14028S sopB::1xFLAG isrM::kanR This study
T-sopE2 ST14028S sopE2::1xFLAG [12]
DM-T-sopE2 ST14028S sopE2::1xFLAG isrM::kanR This study
T-spaO ST14028S spaO::1xFLAG [12]
DM-T-spaO ST14028S spaO::1xFLAG isrM::kanR This study
T-sptP ST14028S sptP::1xFLAG [12]
DM-T-sptP ST14028S sptP::1xFLAG isrM::kanR This study
T-hilE ST14028S hilE::1xFLAG This study
DM-T-hilE ST14028S hilE::1xFLAG isrM::kanR This study
Ec o l iTop10 F- mcrA D(mrr-hsdRMS-mcrBC) Q980lacZDM15 DlacX74 recA1 araD139
D(ara-leu)7697 galU galK rpsL (StrR) endA1 nupG
Invitrogen
Ec o l iTop 10 F9 F9{lacIq Tn10 (TetR)} mcrA D(mrr-hsdRMS-mcrBC) W80lacZDM15 DlacX74
recA1 araD139 D(ara-leu)7697 galU galK rpsL endA1 nupG
Invitrogen
doi:10.1371/journal.ppat.1002120.t001
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FLAG fusion at its carboxyl terminus. By transforming both
plasmids in E.coli, we tested whether the sRNA expression directly
affects the protein level of the FLAG-tagged target gene. The 59
UTR region and the entire coding sequence of hilE were cloned
into a FLAG fusion vector. Transcription of the HilE-FLAG fusion
Figure 3. Expression of the tagged proteins in Salmonella. (A–B) Western blot analyses of the expression of the tagged proteins from bacterial
strains T-sopA and DM-T-sopA (A), and T-sopE2 and DM-T-sopE2 (B). The expression of bacterial DnaK was used as the internal control. Protein
samples were separated in SDS-polyacrylamide gels and reacted with antibodies against the FLAG sequence and DnaK. Each lane was loaded with
lysate prepared from 5610
7 CFU bacteria. (C) The effect of the deletion of the isrM sequence on the expression of SPI-1 proteins. The values of the
relative expression, which are the means of triplicate experiments, represent the ratios of the levels of the tagged proteins in DM-T-invJ, DM-T-sopE2,
DM-T-sptP, DM-T-spaO, DM-T-sipD, DM-T-sipC, DM-T-sipB, DM-T-sipA, DM-T-sopB, and DM-T-sopA to those in T-invJ, T-sopE2, T-sptP, T-spaO, T-sipD,
T-sipC, T-sipB, T-sipA, T-sopB, and T-sopA, respectively.
doi:10.1371/journal.ppat.1002120.g003
Figure 4. Post-transcriptional targeting of hilE and sopA by IsrM. (A–B) Schematic representation of the proposed interactions of IsrM sRNA to
hilE (A) and sopA mRNAs (B), and of compensatory base-pair changes. Numbers indicate relative position to the translational start site of hilE and sopA
or position downstream of the transcriptional start site of isrM. Arrows denote nucleotide substitutions (in box) introduced to IsrM, and hilE and sopA
mRNAs. The SD and AUG sequences are highlighted in blue and red, respectively. (C–D) Western blot analysis of E. coli carrying pLaco-IsrM, pLaco-H-
IsrM and pLaco-S-IsrM, in combination with either wild type or mutant target plasmids, as indicated. The expression of the tagged HilE (C) and SopA
(D) proteins was determined using that of GroEL as the internal control.
doi:10.1371/journal.ppat.1002120.g004
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assay post-transcriptional regulation. The IsrM sequence was
cloned under the control of the IPTG-inducible PLaco promoter,
yielding construct pLaco-IsrM. E.coli transformed with both the
hilE::flag fusion and pLaco-IsrM plasmid was grown and split into
two cultures, only one of which was treated with IPTG. IsrM-
dependent regulation was determined by Western blot analysis of
the HilE-FLAG expression (Figure 4C). Our results showed that
the expression of IsrM significantly reduced HilE-FLAG expres-
sion (Figure 4C, lanes 1 and 2).
To confirm the predicted base-pairing interactions between hilE
mRNA and IsrM, point mutations were introduced to isrM
(U264U265U266 -.A264A265G266) and hilE (G-3A-2A-1 -.U-3U-2U-1)
to generate mutant H-IsrM and m-HilE (Figure 4A). The
expression of HilE-FLAG was not repressed by mutant H-IsrM
(Figure 4C, lanes 3 and 4), while IsrM did not significantly affect the
expression of mutant m-HilE-FLAG (lanes 5 and 6). Repression of
HilE expression by IsrM was restored using m-HilE-FLAG and H-
IsrM, which contained the compensatory mutations (lanes 7 and 8).
To determinethe degree of IsrM over-expression from the plasmids
used and to correlate the level of IsrM expression with the levels of
HilE protein, qRT-PCR assays were performed to determine the
level of IsrM. Table S1 (Supporting Information) shows the relative
levels of IsrM and the respective levels of HilE protein in the
experiments. These results suggest that no significant difference in
the expression levels of IsrM in the presence of IPTG was found in
these experiments, and that base-pairing interactions between the
specific sequences of IsrM (U264U265U266) and HilE mRNA (G-3A-
2A-1) were required for IsrM-mediated downregulation of HilE
protein expression.
To further validate the interactions between IsrM and the hilE
mRNA, an additional pair of compensatory mutations was
introduced to isrM (A257G258C259 -.U257C258G259) and hilE
(G4C5U6 -.C4G5A6) to generate mutants H2-IsrM and m2-HilE,
respectively (Figure 4A). Repression of the m2-HilE-FLAG protein
was restored only by using H2-IsrM, which contained compen-
satory mutations (data not shown). These results suggest that IsrM
inhibits HilE expression by binding to its mRNA around the SD
sequence.
Targeting the 59 UTR of the SopA mRNA by IsrM
Similar experiments were performed to validate the potential
interactions between IsrM and the sopA mRNA. Since the
transcription initiation site of the sopA mRNA has not definitively
been determined, the sequence between the position 61 nt
upstream the translation initiation codon and the position coding
for the 258
th amino acid residue of SopA, which covered the
sequence predicted to interact with IsrM, was cloned into the
PLtetO-1-FLAG fusion vector. E.coli transformed with both the
sopA::flag fusion and pLaco-IsrM plasmid was grown and split into
two cultures, only one of which was treated with IPTG. Western
blot analysis indicated that the expression of IsrM significantly
reduced SopA-FLAG expression (Figure 4D; lanes 9 and 10). To
confirm the predicted potential base-pairing interactions between
IsrM and the sopA mRNA, point mutations were introduced to
isrM (U165C166A167 -.A165G166U167)a n dsopA (U-21G-20A-19 -.
A-21C-20U-19) to generate mutant S-IsrM and M-SopA
(Figure 4B). The expression of SopA-FLAG was not repressed
by S-IsrM (Figure 4D, lanes 11 and 12), while IsrM did not
significantly affect the expression of M-SopA-FLAG (lanes 13 and
14). Repression of M-SopA-FLAG expression was restored by
using S-IsrM, which contained the compensatory mutations
(lanes 15 and 16). To determine the degree of IsrM over-
expression from the plasmids used and to correlate the level of
IsrM expression with the levels of SopA protein, qRT-PCR assays
were performed to determine the level of IsrM. Table S2
(Supporting Information) shows the relative levels of IsrM and the
respective levels of SopA protein in the experiments. These
results suggest that no significant difference in the expression
levels of IsrM in the presence of IPTG was found in these
experiments, and that base-pairing interactions between the
specific sequences of IsrM (U165C166A167) and SopA mRNA (U-
21G-20A-19) were required for IsrM-mediated downregulation of
SopA protein expression.
To further validate the interactions between IsrM and sopA
mRNA, an additional pair of compensatory mutations was
introduced to isrM (U159C160A161 -.A159G160U161) and sopA
(U-15G-14A-13 -.A-15C-14U-13) to generate mutants S2-IsrM and
M2-sopA, respectively (Figure 4B). Repression of the M2-SopA-
FLAG protein was restored only by using S2-IsrM, which
contained compensatory mutations (data not shown). Taken
together, these results suggest that IsrM inhibits SopA expression
by binding to its mRNA around the SD sequence.
Independent targeting of hilE and sopA mRNAs by IsrM in
Salmonella
Since HilE globally regulates the expression of most of SPI-1
proteins including SopA [8], targeting of either hilE or sopA
mRNAs by IsrM is expected to modulate the SopA protein
expression. Consistent with this notion, the expression of SopA in
the isrM deletion mutant DM-T-SopA was suppressed to the
wildtype level only by transformation of plasmid pIsrM (Figure 5,
lane 7), which contained the wild type full length IsrM sequence,
but not by pS-IsrM, which contained mutated IsrM sequence at
the SopA binding site with nucleotide substitutions (U165C166A167
-.A165G166U167) (Figure 5, lane 8). The over-expression of SopA
in DM-T-SopA was also suppressed by transformation of pH-IsrM
(Figure 5, lane 10), which contained mutations in IsrM sequence
that disruptedthe bindingof IsrM to hilE mRNA (U264U265U266 -.
A264A265G266). Interestingly, the SopA level was lower in the pH-
IsrM transformed DM-T-SopA than the pIsrM transformed mutant
(comparelane10tolane7 ofFigure5).Onepossibleexplanationfor
the observation is that pIsrM suppresses HilE while pH-IsrM does
not due to mutations in the hilE mRNA binding site, and therefore
the HilE level in the pH-IsrM transformed mutant is likely higher
than in the pIsrM transformed mutant (compared lane 5 and 2 of
Figure 5). Since HilE negatively regulates SopA and other SPI-1
Figure 5. Western blot analysis of the expression of the tagged
proteins from Salmonella. The tagged proteins were expressed from
strains T-hilE and DM-T-hilE (A), and T-sopA and DM-T-sopA (B). The
expression of bacterial DnaK was used as the internal control. Protein
samples were separated in SDS-polyacrylamide gels and reacted with
antibodies against the FLAG sequence and DnaK. Each lane was loaded
with lysate prepared from 5610
7 CFU bacteria.
doi:10.1371/journal.ppat.1002120.g005
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may lead to further suppression of SopA as compared to the pIsrM
transformed mutant. The expression of tagged HilE protein could
also be reduced to the wildtype level in the isrM deletion mutant
DM-T-hilE by construct pIsrM or pS-IsrM with mutations in the
binding site to sopA mRNA, but not with construct pH-IsrM that
contained mutations in the binding site to hilE mRNA (Figure 5A).
Quantitative RT-PCR assays showed no significant differences in
the expression levels of the wild type and mutant IsrM between
Salmonella carrying complementation constructs pIsrM, pH-IsrM, or
pS-IsrM (data not shown). These observations suggest that IsrM
targets HilE and SopA independently by using different regions to
bind to these mRNAs separately.
Role of IsrM in Salmonella invasion
It is expected that mutations at IsrM, which result in altered
expression levels of HilE, SopA, and other SPI-1 proteins, affect
Salmonella invasion since proper expression of SPI-1 factors is
required for Salmonella entry to nonphagocytosed cells. To
determine whether this is the case, we tested the ability of various
mutant Salmonella strains to invade cultured epithelial cells. A
reduction of about 90% in invasion of HeLa cells was observed in
DIsrM, compared to the wild type ST14028s (Figure 6).
Transformation with the wild type complementation construct
pIsrM restored the ability of DIsrM to invade (Figure 6).
Furthermore, the level of invasion of DIsrM could be restored
by more than 90% with transformation of construct pS-IsrM,
which expressed a mutated IsrM (S-IsrM) with mutations in the
binding site to the sopA mRNA, but not with construct pH-IsrM,
which expressed a mutated IsrM (H-IsrM) with mutations in the
binding site to the hilE mRNA (Figure 6). These results suggest
that IsrM is important for bacterial invasion by modulating the
expression of HilE protein.
Role of IsrM in intracellular survival in macrophages
Intracellular replication in macrophages represents a major
aspect of Salmonella pathogenesis [4,5,6]. The ability of various
strains to proliferate intracellularly was assayed in mouse J774
macrophages [37]. A reduction of about 85% in intracellular
replication was observed in DIsrM, compared to the wild type
ST14028s (Figure 6). Transformation with the wild type
complementation construct pIsrM fully restored the ability of
DIsrM to replicate in macrophages, while the ability of DIsrM to
replicate in J774 cells was also restored by about 80% by
transformation with construct pH-IsrM that expressed the hilE
mRNA binding-defective IsrM mutant (H-IsrM), but not with
construct pS-IsrM that expressed the sopA mRNA binding-
defective IsrM mutant (S-IsrM) (Figure 6). Meanwhile, these
strains, which carried different complementation constructs,
appeared to have no growth defect in vitro as they replicated as
well as the wild type ST14028s strain in LB (Figure S2)(Supporting
Information). These results suggest that IsrM is important for
intracellular proliferation of Salmonella in macrophages by
modulating the expression of SopA protein.
Role of IsrM in bacterial pathogenesis and virulence in
mice
To determine if IsrM is important for pathogenesis in vivo,
BALB/c mice were infected intragastrically with the constructed
isrM mutants. To study the virulence of Salmonella, the survival
rates of the infected animals were determined. When mice were
infected intragastrically with 5610
6 CFU bacteria, all animals
inoculated with the wild type ST14028s strain and DIsrM carrying
complementation construct pIsrM died within 5 days postinfection
(Figure 7A). In contrast, mice infected with DIsrM, and DIsrM
carrying construct pH-IsrM and pS-IsrM remained alive until 15,
12, and 10 days postinfection, respectively. Similar results were
Figure 6. Epithelial cell invasion and intracellular replication in macrophages. Isogenic Salmonella strains carrying different constructs
were added to HeLa cells at a MOI of 10, and cell invasion was assayed by determining the ratio of the number of intracellular bacteria at 1 hour
postinfection to the number of input bacteria. The ratio for wild-type strain ST14028s at 1 h postinfection was arbitrarily defined as 100%, and the
ratios for other samples were expressed as relative values. For the intracellular replication assay, Salmonella was added to J774 macrophages at a MOI
of 10. Intracellular growth was assayed by determining the ratio of the number of intracellular bacteria at 8 hour postinfection to the initial number
of bacteria at time zero. The ratio for wild-type strain ST14028s at 8 h postinfection was arbitrarily defined as 100%, and the ratios for other samples
were expressed as relative values. The data are the averages of three experiments performed in triplicate. The error bars indicate standard deviations.
doi:10.1371/journal.ppat.1002120.g006
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these Salmonella strains (Figure S3)(Supporting Information). These
results suggest that the reduced virulence of DIsrM is due to the
deletion of IsrM and that IsrM is important for Salmonella virulence
in vivo.
To further study the pathogenesis of Salmonella mutants in these
animals, colonization of the mutants in the spleen and ileum was
studied during a 7-day infection period before the onset of
mortality of animals infected with the wild type ST14028s strain.
At 7 days postinfection, the level of colonization of DIsrM carrying
construct pIsrM was similar to that of ST14028s in the organs
examined (Figure 7B). In contrast, the counts of DIsrM in spleens
and ileums of the infected animals were lower than those of the
ST14028s strain by approximately 15,000 and 70,000 fold,
respectively (Figure 7B). The presence of construct pH-IsrM and
pS-IsrM, which contained the mutated IsrM sequences with
mutations that disrupted the interactions of IsrM RNA with the
hilE and sopA mRNAs, respectively, did not completely restore the
ability of mutant DIsrM to colonize these mice. Similar results
were also observed in SCID mice that were intragastrically
infected with these Salmonella strains (Figure S3)(Supporting
Information). These results suggest that the attenuated coloniza-
Figure 7. Virulence and colonization of Salmonella in mice. (A) Mortality of the BALB/c mice infected with isogenic strains carrying different
constructs. BALB/c mice (5 animals per group) were infected intragastrically with Salmonella (5610
6 CFU). (B) The numbers of bacteria (CFU) in spleen
and ileum of the infected animals. Groups of BALB/c (5 animals per group) mice were infected intragastrically (IG) with 1610
5 CFU of isogenic strains
carrying different constructs, and bacteria were recovered from the organs at 7 days post inoculation. Each sample was analyzed in triplicate and the
analysis was repeated at least three times. The CFU of the sample was expressed as the average of the values obtained. The concentrations of
bacteria were recorded as CFU/ml of organ homogenate. The limit of bacteria detection in the organ homogenates was 10 CFU/ml.
doi:10.1371/journal.ppat.1002120.g007
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isrM and that IsrM sRNA may be required for optimal
colonization and growth of Salmonella in these organs in mice.
Discussion
Pathogenicity island-encoded sRNA as a virulence factor
In this report, we presented the first direct evidence that IsrM
modulates the expression of HilE and SopA proteins, and that its
function is important for Salmonella invasion of epithelial cells,
intracellular replication inside macrophages, and virulence and
colonization in mice. A significant number of the sRNAs identified
in Salmonella are encoded in the pathogenicity islands, which are
not present in commensal bacteria or E.coli [23,24,25]. Only two
of these sRNAs, InvR and IsrJ, have been characterized in detail.
InvR, encoded in the SPI-1 region, represses outer membrane
protein synthesis of Salmonella by regulating chromosomal genes
and does not target any genes in the SPIs [24]. IsrJ, whose gene is
located between STM2614 and STM2616, is expressed in the
presence of the major SPI-1 transcription factor, HilA, and an isrJ-
deletion mutant is defective in host cell invasion and effector
translocation in vitro [23]. However, the targets of IsrJ sRNA have
not been identified. Characterization of the mutants with
inactivating InvR and IsrJ RNAs in animals has not been
reported. The roles of either InvR or IsrJ sRNAs in bacterial
pathogenesis and virulence in mice have not been determined.
Our results showed that IsrM sRNA targets the mRNAs of HilE
and SopA independently, leading to down-regulation of expression
of these two proteins. IsrM was expressed in vitro under conditions
resembling those during the initiation of infection in the
gastrointestinal tract (e. g. low pH, oxygen limitation, and high
osmolarity). Furthermore, IsrM was found to be differentially
expressed in vivo, with higher expression in the ileum than in the
spleen. Mutations in IsrM resulted in disregulation of expression of
HilE and SopA, as well as other SPI-1 genes whose expression is
regulated by HilE. Salmonella with a deletion of isrM was defective
in invasion of epithelial cells and intracellular replication/survival
in macrophages, and the defect could be corrected by introduction
of a complementation construct containing the full length isrM
sequence. Moreover, Salmonella with mutations in isrM was
attenuated in its virulence in killing animals and was defective in
colonization in the ileum and spleen in vivo. These results suggest
that IsrM sRNA encodes a virulence factor important for bacterial
infection and demonstrate that a pathogenicity island-encoded
sRNA is directly involved in Salmonella pathogenesis in mice. Our
study raises the possibility that additional pathogenicity island-
encoded sRNA may function in different aspects of Salmonella
pathogenesis, including invasion of epithelium and intracellular
replication in phagocytes.
Differential expression of SPI-1 proteins regulated by
sRNA
The regulation of expression of genes encoding SPI-1 proteins
and its effectors is remarkably complex. For example, the
transcription of many SPI-1 genes can be regulated by HilA,
HilC, HilD, HilE, and PhoP/Q [8]. HilE encodes a global
regulator that negatively modulates the expression of SPI-1 genes
by sequestering HilD, which is a major transcriptional activator
required for expression of most of the SPI-1 genes [35,38]. Our
results indicated that disruption of IsrM-mediated targeting of hilE
mRNA results in increased expression of HilE protein and
disregulated expression of SPI-1 proteins, leading to reduced
invasion efficiency in cultured cells and attenuation of bacterial
virulence and pathogenesis in vivo. Thus, bacterial sRNA presents
another mechanism for global regulation of SPI-1 gene expression.
In addition to globally modulating the expression of SPI-1
proteins through HilE, IsrM also interacts with the mRNA of a
specific SPI-1 effector, SopA. This interaction is likely to be
important as IsrM-mediated modulation of SopA protein
expression affects bacterial intracellular replication in macrophag-
es (Figure 6). SopA has been shown to function as an E3 ubiquitin
ligase regulating host inflammatory responses [39,40]. The level of
this protein is highly regulated in vivo as SopA is found to be
expressed during the early and late stage of Salmonella infection in
vivo, consistent with its role in invasion as well as in intracellular
replication/survival [9,12,13]. Appropriate level of expression of
SopA protein in different cells and at specific time points may
contribute to defined consequences of pathogenesis. This is
consistent with the recent observations that SopA exerts its
functions in concert with other effector proteins during Salmonella
infection of non-phagocytic cells; however, in the context of
systemic infection, its ubiquitin ligase activity may facilitate
bacterial replication in phagocytes [39,41,42]. IsrM can poten-
tially negatively regulate SopA protein level at the translation level
through its direct binding of the sopA mRNA and positively at the
transcriptional level simultaneously through its down-regulation of
the negative regulator HilE. This scenario may represent a novel
mechanism of precise control of bacterial protein levels in a
temporal and tissue/cell specific manner as required for
pathogenesis.
It is currently unclear why IsrM is found in some serovars of
Salmonella but not others. It is possible that the presence of IsrM in
a specific serovar contributes to host specificity in a particular host.
This issue can be investigated further by studying the presence of
IsrM in different serovars and its role in the pathogenesis of
different Salmonella strains in specific hosts in vivo. Our results
indicated that IsrM binds to the 59 UTR regions near the Shine-
Dalgarno (SD) sequence of both the hilE and sopA mRNAs and
inhibits the expression of these two proteins. While it is generally
believed that binding of the SD region by sRNA results in
translation repression, the exact mechanism of how IsrM reduces
the expression of HilE and SopA proteins is currently unknown.
Equally elusive is whether the IsrM-mediated reduction is
mediated by bacterial proteins. The Sm-like RNA-binding protein
Hfq, which has been found to be potentially associated with more
than 40 Salmonella sRNAs [25], acts as a RNA chaperone that
modulates the intracellular stability of many small non-coding
RNAs and their annealing with target mRNAs for translation
repression or stimulation [17,43,44]. It is unclear whether IsrM
RNA is associated with or bound to Hfq, based on recent co-
immunoprecipitation experiments [23,25]. The SopA mRNA was
found to be enriched moderately by co-immunoprecipitation with
anti-Hfq antibodies while the HilE mRNA was not detected in
these experiments [25]. Further studies are needed to characterize
the molecular mechanism of the regulation mediated by IsrM.
It is generally believed that the amounts of various Salmonella
SPI-1 proteins expressed in vivo are in a delicate balance as there
are hierarchical transports of different effectors during Salmonella
entry and extensively ordered synergistic and antagonist relation-
ships between these effectors following their delivery into host cells
[3,45,46]. It is conceivable that the ability of the bacteria to
establish successful infection and cause pathogenesis in specific
tissues may be significantly influenced by the balance of the
amounts of these factors during infection. IsrM was found to be
expressed in vitro under conditions resembling those during the
initial infection in the gastrointestinal tract. Moreover, IsrM was
found to be differentially expressed in vivo, with expression levels
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expression of IsrM is likely a mechanism Salmonella uses to achieve
both global and specific regulation of the expression of SPI-1
proteins in vivo at the appropriate time and place in the host. It
would be interesting to determine the expression patterns of IsrM
as well as other sRNAs and their potential target mRNAs in
different tissues and at different stages of infection in vivo, and study
how their expression affects Salmonella infection. Further charac-
terization of these sRNAs should provide significant insights into
their exact roles in Salmonella infection and pathogenesis.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol for all animal experiments was approved by the Animal
Care and Use Committee of the University of California-Berkeley
(Protocol #R240 and #R276). All efforts were made to minimize
suffering.
Generation of Salmonella mutants and constructs
Table 1 lists the bacterial strains while Table 2 and 3 list the
plasmid constructs and the primers used in the study, respectively.
Salmonella strain DIsrM was derived from S. typhimurium strain
ST14028s by deleting isrM with the l Red recombinase method
[47], following the procedures described previously [48]. Briefly,
primers P5DIsrM and P3DIsrM (Table 3) were used to amplify the
kanamycin resistance gene sequence in plamsid pKD4. The
resulting PCR products were electrophorated into ST14028s
carrying plasmid pKD46. Mutants undergoing homologous
recombination were selected from electroporated ST14028s and
confirmed by PCR using primers P5IsrM and P3IsrM. Once the
deletion mutation was confirmed, the mutation was introduced
into fresh culture of ST14028s by transduction using phage P22,
and P22-free colonies were selected. The non-polar strain DIsrM
was constructed using plasmid pCP20 [47], selected for its
sensitivity to kanamycin, and further confirmed using PCR with
the primers P5IsrM and P3IsrM (Table 3) [12,13,48].
Mutant T-hilE was constructed using the l Red recombinase
method [47], following the procedures as described previously
[12,13,48]. A pair of primers was designed to amplify the FLAG
epitope coding sequence and kanamycin resistance gene using
pUC-H1PF1 as the template [49]. The resulting PCR products
were electroporated into Salmonella ST14028s strain carrying
plasmid pKD46. The non-polar strain T-hilE was constructed
using plasmid pCP20 [47], selected for its sensitivity to kanamycin,
and further confirmed using PCR and subsequent DNA
sequencing. To generate Salmonella strains bearing different tagged
SPI-1 proteins and the isrM-deletion mutation, Salmonella SPI-1
protein-tagged non-polar strains T-invJ, T-sipA, T-sipB, T-sipC,
T-sipD, T-sopA, T-sopB, T-sopE2, T-spaO, T-sptP, which were
previously constructed in our laboratory [12,13], were transduced
with phage P22 carrying the isrM-deletion mutation, following the
procedures described previously [12,13]. Similar procedures were
used to generate mutant DM-T-hilE. The regions for the tagged
ORFs in all the generated tagged strains were sequenced to
confirm that no other mutations were present in these regions
[12,13,48].
To generate complementation plasmids to express the wild type
and mutant IsrM RNA under the control of its native promoter,
plasmid pBR322 was used as the backbone to generate construct
pHG101. Construct pIsrM was generated by inserting to pHG101
with the IsrM sequence generated by PCR with primers P5comp
and P3comp (Table 3) that annealed to a 20-nt sequence located at
208 nucleotides upstream from the transcription initiating site and
51 nucleotides downstream from the transcription terminator of
IsrM, respectively.
In vitro growth analysis of Salmonella
Growth analysis of bacteria in LB broth was carried out by first
inoculating a single colony from a fresh plate in 2 ml LB broth and
culturing at 37uC with shaking at 250 RPM overnight for at least
15 hours [12]. Thirty microliters of the overnight culture were
then inoculated into 3 ml fresh LB broth and cultured at 37uC and
250 RPM. At time points of 0, 2, 4, 6, 8, 10, 12, 14, 16, and
24 hours after inoculation, 100 microliters of bacterial culture
were collected and used for analysis by serial dilution in sterile 96-
well plates, and then plated on LB agar plates to determine their
CFU/ml. Each sample was analyzed in triplicates and the analysis
was repeated at least three times. The average value of CFU/ml
was used to generate the growth curve [12].
Expression of IsrM sRNA in vitro
To study the effect of different culture conditions on the IsrM
expression in vitro,2 0 ml of overnight bacterial cultures were
inoculated into 1 ml of LB broth and shaken at 250 RPM and
37uC for 4 hours. The bacterial cultures were centrifuged at
5,000xg for 5 minutes. To study the effect of pH, the pelleted
bacteria were re-suspended in 1 ml fresh LB broth (control, pH7.0)
or 1 ml LB broth at pH 3.0, 4.4, 5.4, 6.4, 7.2, or 8.4, respectively,
shaken at 250 RPM and 37uC for an additional 3 hours, and then
collected. To study the effect of osmolarity, the pelleted bacteria
were re-suspended in 1 ml NaCl-free LB broth supplemented with
0, 42.5, 85, 160, 340, and 680 mM sodium chloride, respectively,
shaken at 250 RPM and 37uC for an additional 3 hours, and were
collected. Regular LB broth, which contained 170 mM NaCl, was
used as the control. To study the effect of oxygen limitation, the
pelleted bacteria were re-suspended in 1.5 ml fresh LB broth. One
group of bacteria was shaken at 250 RPM and 37uC for an
additional 3 hours with good aeration (control) while another
group of bacteria was transferred into 1.5 ml microcentrifuge tubes
with their covers closed tightly and wrapped with parafilm, and
incubated at 37uC without shaking for an additional 3 hours.
Bacteria were pelleted by centrifugation (2 min, 13,000 rpm, 4uC),
and RNA samples were isolated with the Trizol method
(Invitrogen, Carlsbad, CA), treated with DNase I (TURBO
DNA-free, Ambion, Austin, TX), and used for quantitative RT-
PCR analysis, following the procedures described previously
[13,48,50]. The analyses were repeated three times and the
average of three experiments are presented. For Northern blot
analysis, the Salmonella RNA samples were separated in 2%
agarose gels that contained formaldehyde, transferred to nitrocel-
lulose membranes, hybridized with the [
32P]-radiolabeled DNA
probes that contained the DNA sequence coding for Salmonella
IsrM and 5S RNA, and analyzed with a STORM840 Phosphor-
imager [49].
Validation of IsrM targets in E.coli
The TargetRNA and RNAhybrid programs were used to predict
the target mRNAs of IsrM against the entire genome of Salmonella
typhimurium ST14028s [33,34], and the RNAup software (http://
rna.tbi.univie.ac.at/cgi-bin/RNAup.cgi) was used to analyze the
potential interaction of IsrM to the hilE and sopA mRNAs.
Constructs to validate the targets of IsrM in E.coli were generated
following a modified procedure described previously [36]. To
generate construct pLaco-IsrM expressing IsrM, a 2.2 kb DNA
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-1), an ampicillin resistance cassette, a ColE1 replicon, and a
strong rrnB terminator, was amplified from the high-copy plasmid,
pZE12luc (EXPRESSYS, Ruelzheim, Germany), with primers
P5b-Laco-IsrM and P3b-Laco-IsrM. This DNA fragment was
used as the backbone to ligate with the DNA fragment (generated
in PCR with primers P5i-Laco-IsrM and P3i-Laco-IsrM) contain-
ing the entire IsrM coding sequence and its transcription
terminator sequence, generating construct pLaco-IsrM.
To generate constructs expressing HilE and SopA proteins in
E.coli, the low-copy plasmid, pXG10 (a gift from Dr. J. Vogel,
Germany) [36], was used as the backbone to insert the hilE and
sopA sequence for expression of 16FLAG fusion proteins. The
entire coding sequence of hilE was included in the FLAG-fusion
protein. As hilE has three initiating sites of transcription, three
plasmid constructs (pFG10HilEp1, pFG10HilEp2, and pFG10Hi-
lEp3) were generated to express the HilE-FLAG fusion protein.
Since the transcription initiation site of the sopA mRNA has not
definitively been determined, construct pFG10SopA was generat-
ed to contain the sequence between the position 61 nt upstream
the translation initiation codon and the position coding for the
258
th amino acid residue of SopA, a protein of 782 amino acids
[51]. Constructs expressing mutated isrM and its target genes
carrying different mutations (e.g. pLaco-H-IsrM, pFG10-m-HilE,
pLaco-S-IsrM, and pFG10-M-SopA) were generated by a PCR-
based mutagenesis approach, using primers listed in Table 3.
Expression of tagged proteins in bacteria
To study the expression of tagged proteins in E.coli, the plasmids
for expressing HilE- and SopA-FLAG proteins (e.g. pFG10Hi-
Table 2. Plasmid constructs used in the study.
Plasmids Description Reference/source
pKD4 Containing a kanamycin resistance cassette and the flipase recognition sites [47,48]
pkD46 ApR, containing the Red recombinase of l phage [47]
pCP20 ApR, containing the expression cassette of flipase [47]
pUC-H1PF1 ApR and KanR, template plasmid for 1xFLAG epitope tag [49]
pBR322 ApR, cloning vector, backbone plasmid for constructing sRNA expression complementation
plasmids
New England Biolab
pUC18 ApR, cloning vector Invitrogen
pHG101 ApR; pBR322 with the multiple cloning sequence replaced by that of pUC18 This study
pIsrM ApR, pHG101 containing isrM sequence for complementation of DIsrM mutant This study
pH-IsrM ApR, pIsrM with base substitutions (T264T265T266 -.A264A265G266) at the HilE mRNA binding
site of the isrM sequence
This study
pS-IsrM ApR, pIsrM with base substitutions (T165C166A167 -.A165G166T167) at the SopA mRNA binding
site of the isrM sequence
This study
pZE12-luc ApR, cloning vector for sRNA expression in E.coli Expressys (Germany)
pLaco-IsrM ApR, IsrM expression plasmid for validating the target genes of IsrM in E.coli This study
pLaco-H-IsrM ApR, pLaco-IsrM derivative containing nucleotide substitutions (T264T265T266 -.A264A265G266)
at the HilE mRNA binding site of the isrM sequence
This study
pLaco-H2-IsrM ApR, pLaco-IsrM derivative containing nucleotide substitutions (A257G258C259 -.T257C258G259)
at the HilE mRNA binding site of the isrM sequence
This study
pLaco-S-IsrM ApR, pLaco-IsrM derivative containing nucleotide substitutions (T165C166A167 -.A165G166T167)
at the SopA mRNA binding site of of the isrM sequence
This study
pLaco-S2-IsrM ApR, pLaco-IsrM derivative containing nucleotide substitutions (T159C160A161 -.A159G160T161)
at the SopA mRNA binding site of of the isrM sequence
This study
pXG10 ChlR, expression plasmid for candidate target genes of IsrM in E.coli [36]
pFG10HilEp1 ChlR, pXG10-derivative expression plasmid with the FLAG epitope fused to the 39 end of the
full-length HilE from the promoter 1
This study
pFG10HilEp2 ChlR, pXG10-derivative expression plasmid with the FLAG epitope fused to the 39 end of the
full-length HilE from the promoter 2
This study
pFG10HilEp3 ChlR, pXG10-derivative expression plasmid with the FLAG epitope fused to the 39 end of the
full-length HilE from the promoter 3
This study
pFG10-m-HilE ChlR, pFG10HilEp1 derivative containing nucleotide substitutions (G-3A-2A-1 -.T-3T-2T-1)a tt h e
IsrM binding site of the hilE sequence
This study
pFG10-m2-HilE ChlR, pFG10HilEp1 derivative containing nucleotide substitutions (G4C5T6 -.C4G5A6)a tt h e
IsrM binding site of the hilE sequence
This study
pFG10SopA ChlR, pXG10-derivative expression plasmid with the FLAG sequence fused to the 39 end of
the sopA sequence from -61 nt to +774 nt.
This study
pFG10-M-SopA ChlR, pFG10sopA derivative containing nucleotide substitutions (T-21G-20A-19 -.A-21C-20T-19)
at the IsrM binding site of the sopA sequence
This study
pFG10-M2-SopA ChlR, pFG10sopA derivative containing nucleotide substitutions (T-15G-14A-13 -.A-15C-14T-13)
at the IsrM binding site of the sopA sequence
This study
doi:10.1371/journal.ppat.1002120.t002
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transformed into E coli Top10F ` with pLaco-IsrM and its
derivatives, which contained the wild type and mutated isrM
sequence, respectively. The transformants expressed HilE- and
SopA-FLAG proteins in the presence of 20 mg/ml tetracycline and
expressed isrM and its related RNA in the presence of 1 mM
IPTG. Plasmid pZE12lu (Table 2), which served as the backbone
of RNA expression plasmids for target validation, was used as the
control plasmid.
To determine the effect of the wild type and mutated IsrM RNA
on the expression of HilE and SopA, 60 ml of overnight culture of
E.coli Top10F ` that contained both an expression plasmid for IsrM
and an expression plasmid for SopA- or HilE-FLAG protein was
inoculated in 3 ml of LB broth containing ampicillin (100 mg/ml)
and chloramphenicol (20 mg/ml), and shaken at 37uC, 250 RPM
for 4 hours. Tetracycline and IPTG were added into bacterial
cultures to a final concentration of 20 mg/ml and 1 mM,
respectively, and shaken at 37uC, 250 RPM for an additional six
hours. Bacterial pellets were collected and protein samples were
isolated. Western blot analysis was performed to determine the
levels of the tagged proteins with the expression of GroEL as the
internal control [13,48,50].
To study protein expression in Salmonella, the SPI-1 protein-
tagged strains carrying the deletion mutation of isrM were
inoculated in 2 ml of LB broth and grew at 37uC and 250 RPM
overnight. Sixty microliters of overnight bacterial culture was
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for 6 hours. Protein samples were prepared and Western blot
analysis was performed using the expression of DnaK as the
internal control, following the procedure described previously
[13,48,50]. The analyses were repeated three times.
Western blot analyses
Polypeptides from bacterial lysates were separated on SDS-
containing 10-12% polyacrylamide gels, transferred to nitrocellu-
lose membranes, and reacted with anti-mouse IgG conjugated
with alkaline phosphatase in addition to the antibodies against
DnaK protein (StressGen, Victoria, BC, Canada), GroEL protein
(Sigma, St Louis, MO), or the FLAG sequence (Sigma, St Louis,
MO), following the procedure described previously [13]. The
membranes were subsequently stained with a chemiluminescent
substrate with the aid of a Western chemiluminescent substrate kit
(GE Healthcare, Waukesha, WI) and quantified with a
STORM840 phosphorimager. Normalization of samples was also
carried out by loading total proteins extracted from the same CFU
(e.g. 5610
7 CFU) of bacteria in each lane. Quantitation was
performed in the linear range of protein detection.
Invasion and intracellular replication assays
Assays for bacterial invasion in HeLa cells and intracellular
survival/replication in J774 macrophages were performed as
described previously [37,49,50]. Briefly, Salmonella was added to
HeLa cells at multiplicities of infection (MOI) of 5:1 to 10:1, and
intracellular bacteria were quantified after 1 h of incubation for
invasion, which was followed by incubation in the presence of
50 mg/ml of gentamicin to kill extracellular bacteria. The
invasiveness of Salmonella was measured by determining the ratio
of intracellular bacteria, which was calculated as follows: (number
of intracellular bacteria/number of input bacteria) 6100 [49,50].
To study intracellular growth of Salmonella in macrophages,
mouse J774 macrophages were infected with Salmonella for 1 h at
an MOI of 10, washed with phosphate-buffered saline (PBS), and
then incubated in fresh medium containing 50 mg/ml of
gentamicin for 1 hour. A set of cells was washed and lysed to
quantify the intracellular bacteria and used as the zero-time (0-h)
sample. Additional sets of cells were harvested after an additional 8
h of incubation to quantify intracellular Salmonella (8-h samples).
The growth of Salmonella inside J774 cells was measured by
determining the increase in the number of intracellular Salmonella,
which was calculated by dividing the number of intracellular
bacteria in the 8-h sample by that in the zero-time sample [49,50].
All analyses were repeated three times.
Animal studies
Female BALB/c and SCID mice (6–8 weeks old) were obtained
from Jackson Laboratory (Bar Harbor, ME). Overnight bacterial
cultures were serially diluted to suitable colony forming unit
(CFU)/ml in phosphate-buffered saline (PBS) for infection. To
assess the virulence of the Salmonella strains, mice (5 animals per
group) were either inoculated intragastrically with 5610
6 CFU per
BALB/c mouse and 1610
3 CFU per SCID mouse or intraper-
itoneally with 1610
2 CFU per BALB/c mouse and 1610
1 CFU
per SCID mouse. The survival of the infected animals was
monitored and the survival rate was recorded.
For IsrM sRNA expression and organ colonization experiments,
mice (5 animals per group) were inoculated intraperitoneally with
1610
5 or 1610
7 CFU per BALB/c mouse or 1610
2 or
1610
4 CFU per SCID mouse of the bacterial strains, and were
euthanized at 7 days or 18 hours after inoculation, respectively.
Mice (5 animals per group) were also inoculated intragastrically
with 1610
5 or 1610
8 CFU per BALB/c mouse or 1610
2 or
1610
4 CFU per SCID mouse of the bacterial strains and were
euthanized at 7 days or 18 hours after inoculation, respectively.
Spleen was collected from infected mice, and ileum was dissected
from the small intestine. All organs were homogenized in cold
PBS, and bacterial CFU was determined by plating of serially
diluted organ homogenates [13,48,50]. The analyses were
repeated three times.
To determine the level of IsrM RNA, the homogenates of the
spleen and ileum samples were centrifuged at 9,000xg at 4uC for
10 minutes [13,48,50]. Pellets were incubated in lysis buffer (120
mM NaCl, 4 mM MgCl2, 20 mM Tris/HCl, pH 7.5, 1% Triton-
X100) at 4uC for 1 hour, and released bacteria were collected by
centrifugation at 18,000xg for 10 minutes. Harvested bacteria
were then resuspended in PBS, and adjusted for the bacterial
CFU. RNA samples were prepared from isolated Salmonella and
analyzed by qRT-PCR to determine the expression of IsrM RNA
[13,48,50]. The analyses were repeated three times.
Supporting Information
Figure S1 The levels of IsrM in Salmonella grown in vitro at
pH4.4, pH7.0, and pH7.2, as determined by Northern blot
analyses. The levels of Salmonella 5S RNA were used as the internal
control. The experimental procedures are described in Materials
and Methods. The Salmonella RNA samples were separated in 2%
agarose gels that contained formaldehyde, transferred to nitrocel-
lulose membranes, hybridized with the [
32P]-radiolabeled DNA
probes that contained the DNA sequence coding for Salmonella IsrM
and 5S RNA, and analyzed with a STORM840 Phosphorimager.
(TIF)
Figure S2 Growth analysis of Salmonella strains in LB broth. (A)
The growth of the wild type ST14028s, mutant DIsrM, and DIsrM
transformed with different plasmids. (B) The growth of the wild
type ST14028s and the SPI-1 protein-tagged Salmonella strains.
The experimental procedures are described in Materials and
Methods. The results are the means of three experiments
performed in triplicate. The error bars indicate standard
deviations.
(TIF)
Figure S3 Virulence and colonization of Salmonella in mice. (A)
Mortality of the SCID mice infected with isogenic strains carrying
different constructs. SCID mice (5 animals per group) were
infected intragastrically with Salmonella (1610
3 CFU). (B) The
numbers of bacteria (CFU) in spleen and ileum of the infected
animals. Groups of SCID (5 animals per group) mice were infected
intragastrically (IG) with 1610
2 CFU of isogenic strains carrying
different constructs, and bacteria were recovered from the organs
at 7 days post inoculation. Each sample was analyzed in triplicate
and the analysis was repeated at least three times. The CFU of the
sample was expressed as the average of the values obtained. The
concentrations of bacteria were recorded as CFU/ml of organ
homogenate. The limit of bacteria detection in the organ
homogenates was 10 CFU/ml.
(TIF)
Table S1 Relative levels of IsrM in E. coli transformed with
different constructs, as compared to those in E. coli that expressed
HilE-FLAG and IsrM in the presence of IPTG. Relative levels of
HilE protein in E. coli transformed with different constructs, as
compared to those in the pIsrM-containing E. coli that expressed
HilE-FLAG and m-HilE-FLAG in the absence of IPTG,
respectively.
(DOC)
Salmonella Pathogenicity Island sRNA as a Virulence Factor
PLoS Pathogens | www.plospathogens.org 14 September 2011 | Volume 7 | Issue 9 | e1002120Table S2 Relative levels of IsrM in E. coli transformed with
different constructs, as compared to those in E. coli that expressed
SopA-FLAG and IsrM in the presence of IPTG. Relative levels of
SopA protein in E. coli transformed with different constructs, as
compared to those in the pIsrM-containing E. coli that expressed
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